242 related articles for article (PubMed ID: 8200130)
1. Induction of graft versus host disease in SCID mice by MRL/lpr cell transfer.
Fraziano M; Montesano C; Sammarco I; di Cesare S; Caroleo MC; Mattei M; Cannata S; Poccia F; Bellavia A; Salerno A
Clin Immunol Immunopathol; 1994 Jun; 71(3):265-72. PubMed ID: 8200130
[TBL] [Abstract][Full Text] [Related]
2. Acute graft-versus-host reaction in SCID mice leads to an abnormal expansion of CD8+ V beta 14+ and a broad inactivation of donor T cells followed by a host-restricted tolerance and a normalization of the TCR V beta repertoire in the chronic phase.
Schneider MK; Grönvik KO
Scand J Immunol; 1995 Apr; 41(4):373-83. PubMed ID: 7899825
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of lpr-graft-versus-host disease (GVHD) in MRL/lpr spleen cell-injected SCID mice by in vivo treatment with anti-V beta 8.1,2 monoclonal antibody.
Hosaka N; Nagata N; Miyashima S; Ikehara S
Clin Exp Immunol; 1994 Jun; 96(3):500-7. PubMed ID: 8004820
[TBL] [Abstract][Full Text] [Related]
4. Comparison of wasting syndrome in [MRL lpr/lpr-->MRL +/+] chimera and graft versus host disease in [B10.D2-->BALB/c] chimera and an attempt to transfer the wasting syndrome in [MRL lpr/lpr-->MRL +/+] to MRL +/+ mice.
Aihara M; Aihara Y; Nakajima H
J Dermatol Sci; 1994 Apr; 7(2):107-18. PubMed ID: 7914743
[TBL] [Abstract][Full Text] [Related]
5. CD4-8- T-cells increase in MRI/lpr mice treated with thymic factors.
Mattei M; Bach S; Di Cesare S; Fraziano M; Placido R; Poccia F; Sammarco I; Moras AM; Bardone MR; Colizzi V
Int J Immunopharmacol; 1994 Aug; 16(8):651-8. PubMed ID: 7989133
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of acute graft-vs-host like reaction in [B6-lpr----B6] spleen chimera mice].
Harada H
Hokkaido Igaku Zasshi; 1992 Jul; 67(4):542-51. PubMed ID: 1427598
[TBL] [Abstract][Full Text] [Related]
7. Analyses of lpr-GVHD by adoptive transfer experiments using MRL/lpr-Thy-1.1 congenic mice.
Hosaka N; Nagata N; Nakagawa T; Miyashima S; Yasumizu R; Ikehara S
Autoimmunity; 1994; 17(3):217-24. PubMed ID: 7948606
[TBL] [Abstract][Full Text] [Related]
8. CD3+ T cells in severe combined immunodeficiency (scid) mice. IV. Graft-vs.-host resistance of H-2d scid mice to intravenous injection of allogeneic H-2b (C57BL/6) spleen cells.
Claesson MH; Rudolphi A; Tscherning T; Reimann J
Eur J Immunol; 1991 Sep; 21(9):2057-62. PubMed ID: 1832384
[TBL] [Abstract][Full Text] [Related]
9. Auto-MHC class II-reactive T cell line obtained from MRL/+ mice suffering from lpr-GVHD. II. Analyses of functional characteristics of T cell line by in vivo administration.
Nagata N; Nakagawa T; Hosaka N; Ikehara S
Immunobiology; 1992 Nov; 186(5):339-50. PubMed ID: 1286875
[TBL] [Abstract][Full Text] [Related]
10. MRL/lpr-->severe combined immunodeficiency mouse allografts produce autoantibodies, acute graft-versus-host disease or a wasting syndrome depending on the source of cells.
Ashany D; Hines JJ; Gharavi AE; Mouradian J; Drappa J; Elkon KB
Clin Exp Immunol; 1992 Dec; 90(3):466-75. PubMed ID: 1458684
[TBL] [Abstract][Full Text] [Related]
11. Analyses of acute graft-versus-host-like reaction in [MRL/lpr----MRL/+] chimeric mice using MRL/lpr-Thy-1. 1 congenic mice.
Nakagawa T; Nagata N; Hosaka N; Inaba M; Yasumizu R; Ogawa R; Ikehara S
Cell Immunol; 1991 Oct; 137(1):189-99. PubMed ID: 1679378
[TBL] [Abstract][Full Text] [Related]
12. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment.
Hayashi Y; Haneji N; Hamano H; Yanagi K
Eur J Immunol; 1994 Nov; 24(11):2826-31. PubMed ID: 7957574
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the mechanism of graft-vs-host like disease in [lpr/lpr----+/+] chimera].
Matsunaga T
Hokkaido Igaku Zasshi; 1987 Sep; 62(5):779-89. PubMed ID: 2961673
[TBL] [Abstract][Full Text] [Related]
14. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
[TBL] [Abstract][Full Text] [Related]
15. CD3+ T cells in severe combined immunodeficiency (SCID) mice. V. Allogeneic T cells engrafted into SCID mice do not induce graft-versus-host disease in spite of the absence of host veto and natural suppressor cell activity.
Tscherning T; Rudolphi A; Reimann J; Claesson MH
Scand J Immunol; 1991 Dec; 34(6):795-801. PubMed ID: 1836277
[TBL] [Abstract][Full Text] [Related]
16. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
Rolink AG; Pals ST; Gleichmann E
J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
[TBL] [Abstract][Full Text] [Related]
17. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
Ellison CA; MacDonald GC; Rector ES; Gartner JG
J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation from mutant lpr/lpr mice. Functional abnormalities rather than alloantigenic differences appear to determine the development of a graft-vs.-host-like syndrome.
Allen RD; Marshall JD; Roths JB; Sidman CL
Eur J Immunol; 1990 Sep; 20(9):2057-66. PubMed ID: 2209703
[TBL] [Abstract][Full Text] [Related]
19. Functional analyses of lpr gene in MRL/Mp-lpr/lpr mice. Role of lymph node stromal cells in lpr-lymphadenopathy.
Ohnishi-Inoue Y; Yasumizu R; Sugiura K; Nagata N; Fan H; Oyaizu N; Inaba M; Toki J; Ikehara S
Immunobiology; 1992 Nov; 186(5):449-65. PubMed ID: 1286883
[TBL] [Abstract][Full Text] [Related]
20. The influence of the age of donors and recipients on the regional graft-versus-host reaction in mice.
Skowron-Cendrzak A; Kubera M; Bubak-Satora M; Godowicz W
Arch Immunol Ther Exp (Warsz); 1991; 39(3):185-91. PubMed ID: 1810211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
